Candesartan Improve Regression of Retinopathy in Diabetes Patients

Treatment with candesartan, an angiotensin-receptor blocker, can induce significant improvement in retinopathy patients with type 2 diabetes, irrespective of hypertension status at baseline, according to results from the large multicenter Diabetic Retinopathy Candesartan Trials (DIRECT) presented here at the Association for... (Continue reading)